Yong Chan Kim

This inventor holds 6 USPTO granted patents and 2 published patent applications and 1 EPO patent. Top assignees: The United States of America, as Represented by the Secretary, Department of Health and Human Services, The Henry M. Jackson Foundation for the Advancement of Military Medicine Inc.. Active years: 2000-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Yong Chan Kim. Retrieved from https://idiyas.com/inventor/yong-chan-kim-lm89a80j

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 6 (Patent Applications = 2)

% Patents Active = 100.0

EPO Patents = 1 (Patent Applications = 2)

Average Co-Inventor Count = 1.7

ph-index = 2

Forward Citations = 35(Granted Patents)

Location History:

Newport Beach, CA (US) (2000)
Rockville, MD (US) (2016 - 2021)

Company Filing History:

3 out of 3,699

The United States of America, as Represented by the Secretary, Department of Health and Human Services

patents

2 out of 196

The Henry M. Jackson Foundation for the Advancement of Military Medicine Inc.

patents

where one patent can have more than one assignee

Years Active: 2000-2025

Loading Chart...

6 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12195724 - Methods of producing T cell populations enriched for stable regulatory T-cells (2025-01-14),

2. 11060059 - Methods of producing T cell populations enriched for stable regulatory T-cells (2021-07-13),

3. 10968430 - Use of specific regulatory T-cells to induce immune tolerance (2021-04-06),

4. 10093901 - Use of specific regulatory T-cells to induce immune tolerance (2018-10-09),

5. 9481866 - Methods of producing T cell populations enriched for stable regulatory T-cells (2016-11-01),

6. D434852 - Face rejuvenator (2000-12-05),

Title: Yong Chan Kim: Innovator in T Cell Research

Introduction

Yong Chan Kim is a prominent inventor based in Rockville, MD (US), known for his significant contributions to the field of immunology. With a total of 6 patents, he has focused on developing methods that enhance the production of regulatory T cells, which play a crucial role in immune response regulation.

Latest Patents

One of his latest patents is titled "Methods of producing T cell populations enriched for stable regulatory T-cells." This invention provides innovative methods for culturing T cells to ensure that the final culture is enriched with stable regulatory T cells (Tregs). The patent also discusses techniques for stabilizing these regulatory T cells. The compositions enriched for stable Tregs are particularly useful for treating individuals with immune-mediated diseases.

Career Highlights

Throughout his career, Yong Chan Kim has worked with notable organizations, including the United States of America, as represented by the Secretary, Department of Health and Human Services, and the Henry M. Jackson Foundation for the Advancement of Military Medicine Inc. His work has significantly impacted the understanding and treatment of immune-related conditions.

Collaborations

Yong Chan Kim has collaborated with esteemed colleagues such as Ethan Shevach and David W. Scott, contributing to advancements in the field of immunology.

Conclusion

Yong Chan Kim's innovative work in T cell research has led to valuable patents that enhance our understanding of immune regulation. His contributions are vital for developing new treatments for immune-mediated diseases.

Profile summary based on public USPTO records.